Wambolt & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,247
Closed -$213K 204
2024
Q2
$213K Sell
4,247
-2,129
-33% -$117K 0.06% 192
2024
Q1
$350K Sell
6,376
-6,702
-51% -$349K 0.1% 171
2023
Q4
$737K Sell
13,078
-3,722
-22% -$210K 0.24% 126
2023
Q3
$1.01M Buy
16,800
+2,396
+17% +$152K 0.37% 95
2023
Q2
$851K Buy
14,404
+1,210
+9% +$77K 0.3% 117
2023
Q1
$978K Buy
+13,194
New +$1.02M 0.35% 102

Other funds holding NTR

Wambolt & Associates's NTR Position: Q3 2024 in Review

Wambolt & Associates sold out of Nutrien (NTR) in Q3 2024, closing a stake of 4,247 shares — an estimated $213K sold.

Wambolt & Associates first reported a position in NTR in Q1 2023 and held it in 6 quarters. The position peaked at $1.01M in Q3 2023. 600 funds tracked by Wall St. Rank hold NTR as of Q3 2024.

  • Wambolt & Associates reported no remaining Nutrien position as of Q3 2024 after selling out during the quarter.
  • Wambolt & Associates sold 4,247 Nutrien shares in Q3 2024, an estimated $213K.
  • Wambolt & Associates first reported a position in Nutrien in Q1 2023 and held it in 6 quarters.
  • Wambolt & Associates's Nutrien position peaked at $1.01M in Q3 2023.
  • 600 funds tracked by Wall St. Rank held Nutrien as of Q3 2024.

Based on Wambolt & Associates's 13F filing for Q3 2024, filed 12 Nov 2024.